Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
出版年份 2022 全文链接
标题
Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
作者
关键词
-
出版物
Frontiers in Cardiovascular Medicine
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-05-12
DOI
10.3389/fcvm.2022.903029
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple‐dose study
- (2022) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
- (2022) Jonathan P Piccini et al. LANCET
- Bleeding Risk Assessment in Patients with Venous Thromboembolism
- (2021) Stephan Nopp et al. Hamostaseologie
- Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
- (2021) Shuai Yuan et al. Journal of the American Heart Association
- Contact Activation Inhibitor, AB023, in Heparin-Free Hemodialysis: Results of a Randomized Phase 2 Clinical Trial
- (2021) Christina U. Lorentz et al. BLOOD
- Factor XI Deficiency
- (2021) Magdalena Dorota Lewandowska et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population‐based prospective cohort study
- (2021) Oliver Königsbrügge et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation
- (2021) Seung Min Kim et al. MEDICINE
- Abelacimab for Prevention of Venous Thromboembolism
- (2021) Peter Verhamme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Milvexian for the Prevention of Venous Thromboembolism
- (2021) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
- (2021) Scott C. Woller et al. Blood Advances
- Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD
- (2021) Michael Walsh et al. Kidney International Reports
- Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty
- (2020) Jeffrey I. Weitz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis
- (2020) Toshiki Kuno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in anticoagulant prescribing: a review of local policies in English primary care
- (2020) Katherine H. Ho et al. BMC HEALTH SERVICES RESEARCH
- Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study
- (2020) Saket Sanghai et al. Journal of the American Heart Association
- American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
- (2020) Thomas L. Ortel et al. Blood Advances
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans
- (2019) Alexander W. Koch et al. BLOOD
- AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa
- (2019) Noel C. Chan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial
- (2019) Christina U. Lorentz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI
- (2019) Benjamin Georgi et al. STROKE
- Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer’s Disease and the General Population in Australia
- (2019) Jenni Ilomäki et al. JOURNAL OF ALZHEIMERS DISEASE
- The search for new antithrombotic mechanisms and therapies that may spare hemostasis
- (2018) Edward F. Plow et al. BLOOD
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
- (2018) Vittorio Pengo et al. BLOOD
- Interaction of the Human Contact System with Pathogens—An Update
- (2018) Sonja Oehmcke-Hecht et al. Frontiers in Immunology
- Advances in Antithrombotic Therapy
- (2018) Jeffrey I. Weitz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetically Determined FXI (Factor XI) Levels and Risk of Stroke
- (2018) Dipender Gill et al. STROKE
- Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
- (2017) Neena S. Abraham et al. GASTROENTEROLOGY
- Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous vein
- (2017) C. Ay et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulantes orales directos: puesta al día
- (2017) Ana Isabel Franco Moreno et al. MEDICINA CLINICA
- New developments in anticoagulants: Past, present and future
- (2017) Job Harenberg et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy
- (2016) Megan E. Barra et al. AMERICAN JOURNAL OF MEDICINE
- Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
- (2016) Meir Preis et al. BLOOD
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- Heparin centenary – an ever-young life-saving drug
- (2016) Giangiacomo Torri et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The initiation and effects of plasma contact activation: an overview
- (2016) Lisha Lin et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Contact system revisited: an interface between inflammation, coagulation, and innate immunity
- (2016) A. T. Long et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities
- (2016) A. H. Schmaier JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The hemostatic role of factor XI
- (2016) Cristina Puy et al. THROMBOSIS RESEARCH
- Factor XI and factor XII as targets for new anticoagulants
- (2016) Jeffrey I. Weitz THROMBOSIS RESEARCH
- Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre
- (2015) C. Santoro et al. HAEMOPHILIA
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
- (2014) C. Chai-Adisaksopha et al. BLOOD
- Factor XII inhibition reduces thrombus formation in a primate thrombosis model
- (2014) A. Matafonov et al. BLOOD
- Thrombosis formation on atherosclerotic lesions and plaque rupture
- (2014) L. Badimon et al. JOURNAL OF INTERNAL MEDICINE
- In vivo activation and functions of the protease factor XII
- (2014) Jenny Björkqvist et al. THROMBOSIS AND HAEMOSTASIS
- Epidemiologic and clinical data linking factors XI and XII to thrombosis
- (2014) N. S. Key Hematology-American Society of Hematology Education Program
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
- (2013) Sam Schulman et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Congenital Factor XI Deficiency: An Update
- (2013) Stefano Duga et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
- (2013) Maurits van Montfoort et al. THROMBOSIS AND HAEMOSTASIS
- In vivo roles of factor XII
- (2012) T. Renne et al. BLOOD
- Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
- (2012) H. S. Younis et al. BLOOD
- Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
- (2012) F. PEYVANDI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Factor XI and XII as antithrombotic targets
- (2011) Felicitas Müller et al. CURRENT OPINION IN HEMATOLOGY
- Coagulation factor XI as a novel target for antithrombotic treatment
- (2010) E. C. LÖWENBERG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
- (2010) Ophira Salomon et al. THROMBOSIS AND HAEMOSTASIS
- Factor XI contributes to thrombin generation in the absence of factor XII
- (2009) D. V. Kravtsov et al. BLOOD
- A Tale of Two Anticoagulants: Warfarin and Heparin
- (2009) Charles E. Copeland et al. Journal of Surgical Education
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor XI deficiency--resolving the enigma?
- (2009) P. H. B. Bolton-Maggs Hematology-American Society of Hematology Education Program
- Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
- (2008) E. I. Tucker et al. BLOOD
- Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
- (2008) O. Salomon et al. BLOOD
- Triggers, targets and treatments for thrombosis
- (2008) Nigel Mackman NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started